The global biopsy devices market size is expected to reach USD 3.69 billion by 2028 at a CAGR of 7.1%, according to the latest report by Reports and Data. Rising prevalence of cancer, rise in government initiatives to raise cancer awareness worldwide, increasing need for early diagnosis and prevention of cancer, and growing adoption of minimally invasive surgeries are among the most important parameters expected to drive growth of the global biopsy devices market over the forecast period. Other significant factors driving steady growth of this market are rising prevalence of chronic and infectious diseases, growing adoption of cutting-edge imaging technologies including Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), rapidly advancing global healthcare infrastructure, and increased spending on healthcare services.
Biopsies are medical procedures performed to examine the cause of a particular disease. This process involves removal of tissue from affected part of the body to examine it for disease. They are generally performed for detection of cancers, renal diseases, peptic ulcers, liver inflammation, and various other infections. Punch biopsy, needle biopsy, endoscopic biopsy, fine needle aspiration, and excisional and incisional biopsies are the most widely performed biopsy procedures. With technological advancements in biopsy systems and integration of advanced imaging techniques, such as MRI, CT, ultrasound, and x-ray, the global market has gained rapid traction over recent years. Moreover, increased awareness about benefits offered by biopsy over other invasive diagnostic procedures, such as smaller incisions, lesser pain and scarring, and quicker recovery, is yet another factor expected to propel the global market growth. However, risks associated with surgical biopsies including excessive bleeding, pain and infection in surgical site, and damage to surrounding organs or tissue are predicted to limit market growth to a significant extent.
Key Highlights of the Report:
- Based on product type, the needle-based biopsy instruments segment is expected to account for largest market share over the forecast period. This segment’s growth is principally attributed to growing usage of needle-based biopsy devices in cancer diagnosis, increasing adoption of minimally invasive diagnostic solutions, technological advancements in biopsy devices, and advantages of needle-based biopsies over other biopsy systems.
- North America is the leading regional market for biopsy devices in the global biopsy devices market with the highest revenue share in 2020. The regional market is predicted to display fastest growth in revenue market in the upcoming years owing to rising burden of chronic and infectious diseases, rising prevalence of cancer, rise in government initiatives to raise cancer awareness, and growing focus on early cancer screening. Rise in adoption of advanced biopsy products such as vacuum-assisted biopsy systems and the region’s avant-garde healthcare infrastructure are expected to further boost market growth in North America.
Key Players covered in this report are
Medtronic Plc, Argon Medical Devices, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corp., Cardinal Health, Inc., Danaher Corporation (Leica Microsystem), Hologic, Inc., Devicor Medical Products, Inc., Cook Medical, Inc., Olympus Corporation, INRAD, Inc., and C. R. Bard, Inc.
By Product Type (Revenue, USD Billion; 2018-2028)
- Needle-based Biopsy Instruments
- Core Biopsy Devices
- Core Biopsy Guns
- Core Biopsy Needles
- Vacuum-assisted Biopsy Devices
- Vacuum-assisted Biopsy Systems
- Vacuum-assisted Biopsy Needles
- Aspiration BiopsyNeedles
- Core Biopsy Devices
- Manual and Robotic Biopsy Guidance Systems
- Biopsy Forceps
- Procedure Trays
- Localization Wires
- Others (brushes, punches, curettes, etc.)
By Imaging Technique (Revenue, USD Billion; 2018-2028)
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- CT Scan
- Others
By Application (Revenue, USD Billion; 2018-2028)
- Lung biopsy
- Liver biopsy
- Kidney biopsy
- Gastroenterological biopsy
- Gynecological biopsy
- Breast biopsy
- Prostate biopsy
- Others
By End-use (Revenue, USD Billion; 2018-2028)
- Hospitals
- Diagnostic and Imaging Centers
- Academic Research Institutes
- Others
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Request a sample Report of Biopsy Devices Market @ https://www.reportsanddata.com/sample-enquiry-form/4048
Major Points covered in this report are as below:
• The Biopsy Devices industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.
• The Biopsy Devices Market report provides key statistics on the market status of the Biopsy Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
0 Comments
Post a Comment